Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : PHARMACEUTICALS
LINCOLN PHARMACEUTICALS LTD.
Lincoln Pharmaceuticals Ltd.
NSE: LINCOLN | BSE: 531633
Slowing Down Stock
Download real time
556.25
8.35
(
1.52
%)
43.21% Fall from 52W High
25,492
NSE+BSE Volume
NSE
15 Jul, 2025 3:31 PM (IST)
Watchlist
Portfolio
Alert
Share
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
My Notes
Excel Connect
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Lincoln Pharmaceuticals Ltd. - LINCOLN, 531633 corporate action history
Check all corporate actions such as stock splits, bonuses, dividends, mergers & acquisitions, rights issues & board meeting announcements for Lincoln Pharmaceuticals Ltd.
GET EVENTS ALERTS
LIVE SAMPLE
Daily Digest
Lincoln Pharmaceuticals Ltd. Bonus history
Lincoln Pharmaceuticals Ltd. has not announced any bonus since Jan 1, 2000.
See all forthcoming Bonus and Splits
Split history for Lincoln Pharmaceuticals Ltd.
Lincoln Pharmaceuticals Ltd. has split the face value 2 times since Feb. 8, 2006. Lincoln Pharmaceuticals Ltd. had last split the face value of its shares from ₹2 to ₹10 in 2009.The share has been quoting on an ex-split basis from March 19, 2009.
Ex-Date
Old FV
New FV
Record Date
19 Mar 2009
2
10
26 Mar 2009
08 Feb 2006
10
2
16 Feb 2006
See all forthcoming Bonus and split
Dividend history for Lincoln Pharmaceuticals Ltd.
Lincoln Pharmaceuticals Ltd. has declared 23 dividends since Sept. 23, 2002.
In the past 12 months, Lincoln Pharmaceuticals Ltd. has declared an equity dividend amounting to ₹1.80 per share.
At the current share price of ₹556.2500, Lincoln Pharmaceuticals Ltd.'s dividend yield is 0.32%.
Ex-Date
Dividend Amount
Dividend Type
Record Date
Instrument Type
13 Sep 2024
1.80
FINAL
-
Equity Share
15 Sep 2023
1.50
FINAL
-
Equity Share
15 Sep 2022
1.50
FINAL
-
Equity Share
16 Sep 2021
1.50
FINAL
-
Equity Share
05 Mar 2020
1.50
INTERIM
06 Mar 2020
Equity Share
19 Sep 2019
1.50
FINAL
-
Equity Share
19 Sep 2018
1.50
FINAL
-
Equity Share
21 Sep 2017
1.20
FINAL
-
Equity Share
23 Sep 2016
1.00
FINAL
-
Equity Share
23 Sep 2015
1.00
FINAL
-
Equity Share
25 Sep 2014
0.60
FINAL
-
Equity Share
19 Sep 2013
0.60
FINAL
-
Equity Share
20 Sep 2012
0.60
FINAL
-
Equity Share
22 Sep 2011
0.60
FINAL
-
Equity Share
23 Sep 2010
1.20
FINAL
-
Equity Share
17 Sep 2009
1.20
FINAL
-
Equity Share
18 Sep 2008
0.24
FINAL
-
Equity Share
20 Sep 2007
0.24
FINAL
-
Equity Share
14 Sep 2006
0.24
FINAL
-
Equity Share
25 Aug 2005
1.20
FINAL
-
Equity Share
17 Sep 2004
1.20
FINAL
-
Equity Share
22 Sep 2003
1.20
FINAL
-
Equity Share
23 Sep 2002
1.00
FINAL
-
Equity Share
VIEW MORE
See all forthcoming dividends
Check out stocks with top dividend.
Board Meetings - Lincoln Pharmaceuticals Ltd.
The latest board meeting for Lincoln Pharmaceuticals Ltd. took place on 22 May 2025, for the purpose of Audited Results & Final Dividend
Ex-Date
Purpose
Notes
22 May 2025
Audited Results & Final Dividend
-
13 Feb 2025
Quarterly Results
-
14 Nov 2024
Quarterly Results
-
08 Aug 2024
Quarterly Results
-
16 May 2024
Audited Results & Final Dividend
-
08 Feb 2024
Quarterly Results
-
02 Nov 2023
Quarterly Results
-
10 Aug 2023
Quarterly Results
-
25 May 2023
Audited Results & Dividend
-
09 Feb 2023
Quarterly Results
-
See all Board Meetings for Lincoln Pharmaceuticals Ltd.
Lincoln Pharmaceuticals Ltd. Rights history
Lincoln Pharmaceuticals Ltd. has not issued
any
rights since Jan 1, 2000.
See all Rights History for Lincoln Pharmaceuticals Ltd.